# US 2015/0105644 A1 · Method and/or system for multicompartment analyte monitoring

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105644 A1
- Document ID: US20150105644A1
- Status: Published application
- Kind: A1
- Application number: 14/520,102
- Filed: 2014-10-21
- Published: 2015-04-16
- Earliest claimed: 2011-10-26
- Assignees: Medtronic MiniMed, Inc.
- Applicants: Medtronic Minimed, Inc.
- Inventors: Ning Yang; Rebecca K. Gottlieb; Keith Nogueira; Xialong Li; Bradley Liang
- Web page: https://patentgrep.com/patent/US20150105644A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/1451: {for interstitial fluid}
- A61B 5/4839: {combined with drug delivery}
- A61B 5/6833: {Adhesive patches}
- A61B 5/6849: {in combination with a needle set}
- A61B 5/7239: {using differentiation including higher order derivatives}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- G16H 20/17: delivered via infusion or injection
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 50/50: for simulation or modelling of medical disorders
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/1495: Calibrating or testing of in-vivo probes
- A61B 5/7203: {for noise prevention, reduction or removal}
- A61B 5/725: {using specific filters therefor, e.g. Kalman or adaptive filters (specific diagnostics methods using using bioelectric or biomagnetic signals A61B5/316)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Subject matter disclosed herein relates to monitoring and/or controlling levels of an analyte in bodily fluid. In particular, estimation of a concentration of the analyte in a first physiological compartment based upon observations of a concentration of the analyte in a second physiological compartment may account for a latency in transporting the analyte between the first and second physiological compartments.

## Claims

### Claim 1

A method comprising:
concurrently computing multiple estimators of a concentration of an analyte in a first physiological compartment based, at least in part, on one or more measurements of a concentration of the analyte in a second physiological compartment; and
selecting one of said estimators for determining a patient therapy based, at least in part, on a performance metric, wherein said selected estimator is based, at least in part on a modeled latency in transportation of said analyte between said first and second physiological compartments.

### Claim 2 (depends on 1)

The method of claim 1, wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

### Claim 3 (depends on 1)

The method of claim 1, wherein said one or more measurements are obtained based, at least in part, on one or more values of a sensor signal, and wherein the modeled latency is based, at least in part, on an estimated rate of change in the sensor signal.

### Claim 4 (depends on 3)

The method of claim 3, wherein said sensor signal comprises a current responsive to the concentration of said analyte in said second physiological compartment.

### Claim 5 (depends on 1)

The method of claim 1, wherein the modeled latency is based, at least in part, on a latency of a presence of glucose in a patient's interstitial fluid to affect a blood glucose concentration in said patient.

### Claim 6 (depends on 1)

The method of claim 1, wherein said performance metric comprises a mean absolute relative difference between reference samples of said concentration of said analyte in the first physiological compartment and estimates of said concentration of said analyte in the first physiological compartment computed according to said selected estimator.

### Claim 7 (depends on 6)

The method of claim 6, wherein said selected estimator is based, at least in part, on a plurality of estimated parameters including an estimate of a latency in transportation of said analyte between said first and second physiological compartments.

### Claim 8 (depends on 1)

The method of claim 1, wherein said patient therapy comprises control of an insulin pump.

### Claim 9

An apparatus comprising:
a sensor to generate a signal responsive to a concentration of an analyte in a second physiological compartment; and
a processor to:
concurrently compute multiple estimators of a concentration of the analyte in a first physiological compartment based, at least in part, on one or more measurements of the concentration of the analyte in the second physiological compartment based, at least in part, on said signal; and
select one of said estimators for determining a patient therapy based, at least in part, on a performance metric, wherein said selected estimator is based, at least in part on a modeled latency in transportation of said analyte between said first and second physiological compartments.

### Claim 10 (depends on 9)

The apparatus of claim 9, wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

### Claim 11 (depends on 9)

The apparatus of claim 9, wherein said modeled latency is based, at least in part, on an estimated rate of change in said signal.

### Claim 12 (depends on 11)

The apparatus of claim 11, wherein said signal comprises a current responsive to the concentration of said analyte in said second physiological compartment.

### Claim 13 (depends on 9)

The apparatus of claim 9, wherein the modeled latency is based, at least in part, on a latency of a presence of glucose in a patient's interstitial fluid to affect a blood glucose concentration in said patient.

### Claim 14 (depends on 9)

The apparatus of claim 9, wherein said performance metric comprises a mean absolute relative difference between reference samples of said concentration of said analyte in the first physiological compartment and estimates of said concentration of said analyte in the first physiological compartment computed according to said selected estimator.

### Claim 15 (depends on 14)

The apparatus of claim 14, wherein said selected estimator is based, at least in part, on a plurality of estimated parameters including an estimate of a latency in transportation of said analyte between said first and second physiological compartments.

### Claim 16 (depends on 9)

The apparatus of claim 9, and further comprising an insulin pump, wherein the processor is further to control said insulin pump based, at least in part, on said determined patient therapy

### Claim 17

An article comprising:
a non-transitory storage medium having machine-readable instructions stored thereon which are executable by a special purpose computing apparatus to:
concurrently compute multiple estimators of a concentration of an analyte in a first physiological compartment based, at least in part, on one or more measurements of a concentration of the analyte in a second physiological compartment; and
select one of said estimators for determining a patient therapy based, at least in part, on a performance metric, wherein said selected estimator is based, at least in part on a modeled latency in transportation of said analyte between said first and second physiological compartments.

### Claim 18 (depends on 17)

The article of claim 17, wherein the analyte comprises glucose, the first physiological compartment comprises blood plasma, and the second physiological compartment comprises interstitial fluid.

### Claim 19 (depends on 17)

The article of claim 17, wherein said performance metric comprises a mean absolute relative difference between reference samples of said concentration of said analyte in the first physiological compartment and estimates of said concentration of said analyte in the first physiological compartment computed according to said selected estimator.

### Claim 20 (depends on 19)

The article of claim 19, wherein said selected estimator is based, at least in part, on a plurality of estimated parameters including an estimate of a latency in transportation of said analyte between said first and second physiological compartments.
